Published: September 2022
Given the increased demand for biologics and various benefits of single-use technology, the biopharmaceutical manufacturers are gradually adopting single-use systems for various downstream processes of biologics manufacturing
Roots Analysis has announced the addition of “Single-use Downstream Bioprocessing Technology Market, 2022-2035” report to its list of offerings.
Single-use technologies offer multiple benefits and have gradually garnered interest of stakeholders in biopharmaceutical industry. These technologies not only lower down the footprint requirement and risk of contamination, but also eliminate the cleaning costs. Additionally, the single-use technologies have the potential to address a number of challenges associated with traditional bioprocessing systems.
To order this 200+ slides report, which features 120+ figures and tables, please visit link
Over 210 single-use equipment have been developed for downstream bioprocessing technologies
Single-use downstream technology equipment comprises of connectors (33%), filtration systems (32%), and chromatography systems (14%), sampling systems (14%), and centrifugation systems (7%) that can be used in manufacturing of a variety of molecules, including monoclonal antibodies, vaccines, and therapeutic proteins/hormones.
Over 25+ companies claim to provide single-use downstream equipment
Majority of the single-use downstream bioprocessing technology developers are headquartered in North America (58%), followed by Europe (34%) and Asia-Pacific (8%).
Till date, 410+ patents have been filed / granted related to single-use downstream bioprocessing technology
More than 65% of these were patent applications, while the remaining were granted patents. Of the total patent applications, over 95% were filed by the industry players, while close to 5% patents were filed by the non-industry players.
Asia-Pacific is anticipated to capture largest share of the global single-use downstream bioprocessing technology market, by 2035
Single-use downstream bioprocessing technology equipment developed for preclinical / clinical scale operations currently capture the highest share (over 65%) in the market; however, in the foreseen future majority of the market share is expected to be driven by the commercial scale operations.
To request a sample copy / brochure of this report, please visit link
By 2035, the financial opportunity within the single-use downstream bioprocessing technology market has been analyzed across the following segments:
The research report includes profiles of key players (listed below); each profile features an overview of company, service portfolio, single-use downstream technology product portfolio, recent developments, and an informed future outlook.
For additional details, please visit link https://www.rootsanalysis.com/reports/single-use-downstream-bioprocessing-market.html or email email@example.com
You may also be interested in the following titles:
+1 (415) 800 3415
+44 (122) 391 1091
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES